Sure Medical, Inc., a subsidiary of Biomed Research Technologies, Inc., is an American company that develops drugs for the improved therapy for respiratory disease, glaucoma, anaphylaxis and other diseases. The firm was acquired by Biomed Research Technologies, Inc. on May 29, 2001.

SyntheX created a novel cell-based, synthetic biology-driven drug selection platform, that allows for the efficient synthesis and identification of peptides and macrocycles that selectively disrupt intracellular protein-protein interactions of interest. Although the platform has broad application, the initial focus is on oncology. Targets are selected based on the concepts of synthetic lethality and oncogene addiction, with the first program focused on DNA damage repair and working through a novel cell death mechanism that was uncovered.

Jiangsu Kanion Pharma is a pharmaceuticals company based out of LIANYUNGANG. Jiangsu Kanion Pharma representatives, don’t miss out on opportunities to build relationships with members on LinkedIn. Claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees.

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Roche Palo Alto, engages in the discovery, development, and marketing of medicines for inflammatory or viral diseases. The company provides medicines for the treatment for a range of diseases, including severe asthma, chronic obstructive pulmonary disease, and rheumatoid arthritis. The company was formerly known as Syntex (U.S.A.) LLC and changed its name in 1994. The company was incorporated in 1960 and is based in Palo Alto, California. Roche Palo Alto, LLC operates as a subsidiary of Roche Holding AG. Source (businessweek) {http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=8102245}

Shanghai Chengyu Medical Technology Co., Ltd., established on 2017-07-24, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Medical Device Technology,health technology,Technology development in the field of biotechnology,Technical Services,technical consulting,technology transfer,medical consultation,Health Advisory(Does not include medical services),Medical Equipment Leasing,e-commerce(Not to engage in financial business),Advertising Design,make,acting,advertising(non-broadcasting station,television station,Newspaper Publishing Unit),Class II medical device,Daily necessities,Clothes, shoes,handcrafted gift,furniture,Computer hardware and software,hardware products,household appliances,Sales of machinery and equipment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wuxi Lanyang Harmonic Technology Co., Ltd., established on 2013-04-27, Business scope includes precision machinery,Research and development of harmonic reducer,processing,manufacture,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nissui Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of culture media and diagnostic reagents for medical institutions, research organizations, and food industries. It operates through the Clinical Diagnostics and Pharmaceuticals segment. The Clinical Diagnostics segment provides reagents and instruments for microbiological and immunological tests. The Pharmaceuticals segment offers over-the-counter pharmaceutical products and health food supplements. The company was founded on April 6, 1935 and is headquartered in Tokyo, Japan.

Institute of Laboratory Animal Science, a subsidiary of University of Zurich, is a Swiss company located in Schlieren that provides research, services and teaching in translational and basic research.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Provides research services for the biomedical industry

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

BIOMEDICA FOSCAMA INDUSTRIA Chimico-Farmaceutica SpA operates pharmaceutical and drug stores. Its products include Esafosfina, TAD, Ursolac, and CV & CNS drugs. The company provides products in the areas of metabolism and parenteral nutrition. BIOMEDICA FOSCAMA INDUSTRIA Chimico-Farmaceutica was founded in 1947 and is headquartered in Ferentino, Italy

Atomization Health Industry Group (Hainan) Co., Ltd., established on 2021-10-12, Business scope includes licensed projects:medical service;food sales;Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Socioeconomic Advisory Services;Tourism development project planning consultation;Rural folk crafts and products,Development and management of leisure agriculture and rural tourism resources;R&D and application of cell technology;Remote Health Management Services;Health Consulting Services(Does not include medical services);internet sales(Except for products that require a license for sale);Production of protective equipment for medical personnel(Ι class medical device);Production of Class I Medical Devices;Sales of Class I Medical Devices;Information system integration service;Artificial intelligence application software development;Natural science research and experimental development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Intelligent Agricultural Management;Agricultural production hosting service;Technology related to agricultural production and operation,information,Facilities construction and operation services;Agricultural professional and auxiliary activities;Supply Chain Management Services;Cosmetics Retail;Cosmetics Wholesale;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Manufacture of special equipment for daily chemical industry;Sales of daily chemical products;Manufacturing of daily chemical products;spice crops;Government Procurement Agency Services(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Zhejiang Youxin Intelligent Medical Technology Co., Ltd., established on 2016-11-14, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Manufacturing of plastic products;Sales of plastic products;mold making;Mold Sales;Mechanical Parts,Parts processing;Mechanical Parts,Parts sales;Mechanical equipment research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.